Global mRNA Platform Market Research Report 2023

Publication ID:

PB510235073

Publication Date:

October 3, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The mRNA platform refers to a technology and method used for vaccine development and gene therapy. mRNA, or messenger RNA, is a single-stranded molecule that carries genetic information from DNA to the ribosomes in cells, where it is translated into proteins. In the mRNA platform, synthetic mRNA molecules containing the genetic code for a specific protein are delivered into cells to instruct them to produce that protein.
The global mRNA Platform market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole mRNA Platform 91制片厂.
Key companies engaged in the mRNA Platform industry include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of mRNA Platform were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole mRNA Platform market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global mRNA Platform market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The mRNA Platform report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Platform Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Platform Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Platform Market Perspective (2018-2029)
2.2 mRNA Platform Growth Trends by Region
2.2.1 Global mRNA Platform Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 mRNA Platform Historic Market Size by Region (2018-2023)
2.2.3 mRNA Platform Forecasted Market Size by Region (2024-2029)
2.3 mRNA Platform Market Dynamics
2.3.1 mRNA Platform Industry Trends
2.3.2 mRNA Platform Market Drivers
2.3.3 mRNA Platform Market Challenges
2.3.4 mRNA Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Platform Players by Revenue
3.1.1 Global Top mRNA Platform Players by Revenue (2018-2023)
3.1.2 Global mRNA Platform Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Platform Revenue
3.4 Global mRNA Platform Market Concentration Ratio
3.4.1 Global mRNA Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Platform Revenue in 2022
3.5 mRNA Platform Key Players Head office and Area Served
3.6 Key Players mRNA Platform Product Solution and Service
3.7 Date of Enter into mRNA Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Platform Breakdown Data by Type
4.1 Global mRNA Platform Historic Market Size by Type (2018-2023)
4.2 Global mRNA Platform Forecasted Market Size by Type (2024-2029)
5 mRNA Platform Breakdown Data by Application
5.1 Global mRNA Platform Historic Market Size by Application (2018-2023)
5.2 Global mRNA Platform Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America mRNA Platform Market Size (2018-2029)
6.2 North America mRNA Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America mRNA Platform Market Size by Country (2018-2023)
6.4 North America mRNA Platform Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Platform Market Size (2018-2029)
7.2 Europe mRNA Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe mRNA Platform Market Size by Country (2018-2023)
7.4 Europe mRNA Platform Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Platform Market Size (2018-2029)
8.2 Asia-Pacific mRNA Platform Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific mRNA Platform Market Size by Region (2018-2023)
8.4 Asia-Pacific mRNA Platform Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Platform Market Size (2018-2029)
9.2 Latin America mRNA Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America mRNA Platform Market Size by Country (2018-2023)
9.4 Latin America mRNA Platform Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Platform Market Size (2018-2029)
10.2 Middle East & Africa mRNA Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa mRNA Platform Market Size by Country (2018-2023)
10.4 Middle East & Africa mRNA Platform Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arcturus Therapeutic
11.1.1 Arcturus Therapeutic Company Detail
11.1.2 Arcturus Therapeutic Business Overview
11.1.3 Arcturus Therapeutic mRNA Platform Introduction
11.1.4 Arcturus Therapeutic Revenue in mRNA Platform Business (2018-2023)
11.1.5 Arcturus Therapeutic Recent Development
11.2 Argos Therapeutics
11.2.1 Argos Therapeutics Company Detail
11.2.2 Argos Therapeutics Business Overview
11.2.3 Argos Therapeutics mRNA Platform Introduction
11.2.4 Argos Therapeutics Revenue in mRNA Platform Business (2018-2023)
11.2.5 Argos Therapeutics Recent Development
11.3 BioNTec
11.3.1 BioNTec Company Detail
11.3.2 BioNTec Business Overview
11.3.3 BioNTec mRNA Platform Introduction
11.3.4 BioNTec Revenue in mRNA Platform Business (2018-2023)
11.3.5 BioNTec Recent Development
11.4 CureVac
11.4.1 CureVac Company Detail
11.4.2 CureVac Business Overview
11.4.3 CureVac mRNA Platform Introduction
11.4.4 CureVac Revenue in mRNA Platform Business (2018-2023)
11.4.5 CureVac Recent Development
11.5 Etherna
11.5.1 Etherna Company Detail
11.5.2 Etherna Business Overview
11.5.3 Etherna mRNA Platform Introduction
11.5.4 Etherna Revenue in mRNA Platform Business (2018-2023)
11.5.5 Etherna Recent Development
11.6 Ethris
11.6.1 Ethris Company Detail
11.6.2 Ethris Business Overview
11.6.3 Ethris mRNA Platform Introduction
11.6.4 Ethris Revenue in mRNA Platform Business (2018-2023)
11.6.5 Ethris Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline mRNA Platform Introduction
11.7.4 GlaxoSmithKline Revenue in mRNA Platform Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer mRNA Platform Introduction
11.8.4 Pfizer Revenue in mRNA Platform Business (2018-2023)
11.8.5 Pfizer Recent Development
11.9 Translate Bio
11.9.1 Translate Bio Company Detail
11.9.2 Translate Bio Business Overview
11.9.3 Translate Bio mRNA Platform Introduction
11.9.4 Translate Bio Revenue in mRNA Platform Business (2018-2023)
11.9.5 Translate Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.